New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2014
07:17 EDTSYKStryker should be bought at current levels or on pullbacks, says RBC Capital
After Stryker's results beat expectations, RBC Capital continues to believe that the company is well-positioned to remain one of the fastest growing medtech companies in 2014. The firm identifies Stryker as one of its favorite ideas for 2014 and keeps an Outperform rating on the stock.
News For SYK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
07:12 EDTSYKCongress of Neurological Surgeons to hold annual meeting
Subscribe for More Information
October 17, 2014
07:45 EDTSYKStryker price target lowered to $84 from $88 at Canaccord
Subscribe for More Information
October 16, 2014
16:04 EDTSYKStryker sees FY14 adjusted EPS at low end of $4.75-$4.80 guidance
Subscribe for More Information
16:02 EDTSYKStryker reports Q3 adjusted EPS $1.15, consensus $1.14
Reports Q3 revenue $2.39B, consensus $2.32B.
15:26 EDTSYKNotable companies reporting after market close
Subscribe for More Information
October 14, 2014
12:33 EDTSYKZimmer, Stryker have postive read-through from J&J, says Wells Fargo
Subscribe for More Information
11:11 EDTSYKJohnson & Johnson Ortho strength positive for Zimmer, says Piper Jaffray
Piper Jaffray said Johnson & Johnson's (JNJ) sequential Q3 strength in orthopedics, which included acceleration in both hips and knees, was surprising and a positive for Zimmer (ZMH). However, Piper expect sentiments on ortho names to remain muted until further into reporting season, noting that Stryker (SYK) is scheduled to report Thursday after the close. The firm has Neutral rating on Johnson & Johnson and Stryker and an Overweight rating on Zimmer.
October 10, 2014
07:16 EDTSYKAmerican Society of Plastic Surgeons to hold annual meeting
Annual Meeting of ASPS is being held in Chicago on October 10-14.
October 9, 2014
06:18 EDTSYKBiomet reports Q1 sales up 6% to $775M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use